campylobacter jejuni strain bh-01-0142
Cell therapyexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2007 (NCT00434798)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- microbiotaTissue restoration
microbiota tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- campylobacter jejuni strain bh-01-0142
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00434798 | Phase 1 | Feb 1, 2007 | TD Vaccines A/S, United States Navy, University of Vermont |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| TD Vaccines A/S | For profit | 1 | 0 | 1 | 2007 |
| United States Navy | Government | 1 | 0 | 1 | 2007 |
| University of Vermont | Academic/Hospital | 1 | 1 | 1 | 2007 |
3 organizations
Page 1 / 1